Sue Bacon on the Importance of Addressing Hospital-Acquired DVT and PE
Sue Bacon, VTE specialist – Quality Improvement at North Bristol NHS Trust, reposted from Firstkind Ltd on LinkedIn:
”It’s so important to ask this question – hospital acquired DVT and PE is not uncommon, and sometimes linked to lack of an assessment of your individual risk, but also, sadly, because patients do not understand enough and refuse the medication/devices.
Please, please ask.”
Firstkind Ltd shared on LinkedIn:
”Did you know?
More people die each year in the UK from hospital-acquired venous thromboembolism (VTE) than from breast cancer, AIDS, and traffic accidents combined.
VTE is a leading cause of preventable death in hospitals — yet it’s often overlooked.
The good news? Most cases are entirely preventable with timely risk assessments and appropriate treatment.
Innovative technologies like the geko device, which stimulates blood flow in the lower leg, are helping reduce VTE risk when traditional methods aren’t suitable.
If you or a loved one is admitted to hospital, don’t be afraid to ask: ‘Have I been assessed for blood clots?”

Stay updated with Hemostasis Today.
-
Nov 6, 2025, 08:24Jacqui McCallum Reflects on Meeting with The Royal Melbourne Hospital Stroke and Neurology Ward Team
-
Nov 6, 2025, 08:17Maxime Dely: The True Heroes of Blood Donation Are Them!
-
Nov 6, 2025, 07:11Francesco Giurazza on Radial Access for Liver Transarterial Chemoembolization
-
Nov 6, 2025, 07:04Andrea Van Beek: Proud to be a Certified Anticoagulation Care Provider (CACP)!
-
Nov 6, 2025, 06:57Jian-Ke Tie’s Team on Comorbidity of VitK-dependent Clotting Factors Deficiency and Chondrodysplasia Punctata
-
Nov 6, 2025, 04:17Aakanksha A To Present Insights from ASH Education Social Media Initiative at 67th ASH Meeting
-
Nov 6, 2025, 04:03Yaping Zhang on Two-Way GPIb-IX Signaling in Platelet Activation and VWF Binding
-
Nov 6, 2025, 03:38Thierry Burnouf on Platelet-Derived Extracellular Vesicles and Their Role in Neurogenesis
-
Nov 6, 2025, 03:29Shubham Misra to Present 3 Abstracts at International Stroke Conference 2026
